Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser

Platelets

Volumn 24, Issue 4, 2013, Pages 303-307

  Johnston, Lisa R ^a,b   Larsen, Peter D ^b,d   La Flamme, Anne C ^a,b   Harding, Scott A ^a,b,c  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b Wellington Cardiovascular Research Group   (New Zealand)

^c WELLINGTON HOSPITAL   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

ACS; Antiplatelet; Methodology; Multiplate; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM CHLORIDE; CITRATE SODIUM; HEPARIN; HIRUDIN;

ANTICOAGULATION; ARTICLE; HUMAN; HUMAN CELL; PIPETTE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION ANALYZER;

ADENOSINE DIPHOSPHATE; ANTICOAGULANTS; BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84876130984     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.694086     Document Type: Article

References (22)

1. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-3175
2. Aradi D, Komocsi A, Vorobcsuk A, Rideg O, Tokes-Fuzesi M, Magyarlaki T, Horvath IG, Serebruany VL. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis. Am Heart J. 2010;160:543-551
3. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, et al. Consensus and future directions on the definition of high ontreatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919-933
4. Multiplate. http://www.multiplate.net/en/index.php 5. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drugeluting stent thrombosis. J Am Coll Cardiol. 2009;53:849-856
5. Sibbing DS, Schulz SR, Schomig S, Kastrati A. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients. JAm Coll Cardiol. 2010;56:317-318
6. Paniccia R, Antonucci E, Maggini N, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Am J Clin Pathol. 2009;131:834-842
7. Breugelmans J, Vertessen F, Mertens G, Gadisseur A, Van der Planken M. Multiplate whole blood impedance aggregometry: A recent experience. Thromb Haemost. 2008;100:725-726
8. Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost. 2010;104:287-292
9. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets. 2007;18:199-206
10. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost. 2008;99:121-126
11. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006;96:781-788
12. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol. 2008;52:1128-1133
13. Paniccia R, Antonucci E, Gori AM, Marcucci R, Giglioli C, Antoniucci D, Gensini GF, Abbate R, Prisco D. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost. 2007;5:1839-1847
14. Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost. 2010;8:351-359
15. Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schomig A, von Beckerath N, Kastrati A. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost. 2010;8:250-256
16. Marciniak Jr SJ, Jordan RE, Mascelli MA. Effect of Ca2 chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban. Thromb Haemost. 2001;85:539-543
17. Mousa SA, Bozarth JM, Forsythe MS, Slee A. Differential antiplatelet efficacy for various GPIIb/IIIa antagonists. Cardiovasc Res. 2000;47:819-826
18. Kalb ML, Potura L, Scharbert G, Kozek-Langenecker SA. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets. 2009;20:7-11
19. Harding SA, Din JN, Sarma J, Josephs DH, Fox KAA, Newby DE. Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin. Heart. 2006;92:1635-1638
20. Thomson C, Forbes CD, Prentice CR. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med. 1973;45:485-494
21. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980;65:64-73
22. Heinrich D, Gorg T, Schulz M. Effects of unfractionated and fractionated heparin on platelet function. Haemostasis. 1988;18 Suppl 3:48-54